Robert E. Conway

Director, Oruka Therapeutics, Inc.

Companies

Alpine Immune SciencesBoard member Jun 16, 2015 to May 20, 2024¹
Oruka Therapeutics, Inc.Board member Sep 4, 2013 to Jan 31, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Oruka Therapeutics, Inc. ORKA50,000 shares³$3.7M at $73.87Jan 31, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

May 20, 2024Returned to company 50,000 shares of CIK 1626199⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAlpine Immune Sciences, Board member
2
SEC EDGAROruka Therapeutics, Inc., Board member
3
SEC EDGAROruka Therapeutics, Inc. shares after the filing of Jan 31, 2024
4
SEC EDGARForm 4 filed May 20, 2024